Company intelligence / Profile preview

Rapha Pharmaceuticals

Orlando, Florida, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Rapha Pharmaceuticals commercially markets products like Morning After® (levonorgestrel; emergency contraception) and compounds GLP-1 and other peptide formulations, focusing on areas with neglected or unmet medical needs such as women’s health, sleep, pain, and sexual health. Clinical trial or novel therapeutic data beyond marketed products are not directly disclosed.

Therapeutic areas: NeurologyInfectious DiseasesWomen's Health
Modalities: Small moleculePeptidesHormoneBiologic
Industry: Biotech

Beyond the preview

Go deeper on Rapha Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rapha Pharmaceuticals.

Explore the full profile